RU94046367A - Днк, хозяйская клетка, способ получения белка, белок, фармацевтический препарат, антитело, применение антитела - Google Patents
Днк, хозяйская клетка, способ получения белка, белок, фармацевтический препарат, антитело, применение антителаInfo
- Publication number
- RU94046367A RU94046367A RU94046367/13A RU94046367A RU94046367A RU 94046367 A RU94046367 A RU 94046367A RU 94046367/13 A RU94046367/13 A RU 94046367/13A RU 94046367 A RU94046367 A RU 94046367A RU 94046367 A RU94046367 A RU 94046367A
- Authority
- RU
- Russia
- Prior art keywords
- proteins
- protein
- antibody
- preparing
- tgf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Изобретение обеспечивает последовательности ДНК, кодирующие новые члены семейства белков TGF-β.. Семейство TGF-β содержит белки, которые функционируют в качестве факторов роста и/или дифференциации и применимы в медицине. В соответствии с этим, изобретение описывает также выделение вышеупомянутых последовательностей ДНК, экспрессию кодируемых ими белков, получение этих белков и фармацевтические композиции, содержащие эти белки.
Claims (1)
- Изобретение обеспечивает последовательности ДНК, кодирующие новые члены семейства белков TGF-β.. Семейство TGF-β содержит белки, которые функционируют в качестве факторов роста и/или дифференциации и применимы в медицине. В соответствии с этим, изобретение описывает также выделение вышеупомянутых последовательностей ДНК, экспрессию кодируемых ими белков, получение этих белков и фармацевтические композиции, содержащие эти белки.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92102324 | 1992-02-12 | ||
DE92102324.8 | 1992-02-12 | ||
EP92102324.8 | 1992-02-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94046367A true RU94046367A (ru) | 1997-03-27 |
RU2208638C2 RU2208638C2 (ru) | 2003-07-20 |
Family
ID=8209321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94046367/13A RU2208638C2 (ru) | 1992-02-12 | 1993-02-12 | Днк (варианты), способ получения белка, белок, фармацевтическая композиция |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0625989B1 (ru) |
JP (2) | JP3193050B2 (ru) |
KR (1) | KR0172186B1 (ru) |
AT (1) | ATE188996T1 (ru) |
CA (1) | CA2129820C (ru) |
CZ (2) | CZ287715B6 (ru) |
DE (1) | DE69327645T2 (ru) |
DK (1) | DK0625989T3 (ru) |
ES (1) | ES2141761T3 (ru) |
GR (1) | GR3032482T3 (ru) |
HU (1) | HU218845B (ru) |
NZ (1) | NZ249113A (ru) |
PT (1) | PT625989E (ru) |
RU (1) | RU2208638C2 (ru) |
UA (1) | UA48105C2 (ru) |
WO (1) | WO1993016099A2 (ru) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6586388B2 (en) | 1988-04-08 | 2003-07-01 | Stryker Corporation | Method of using recombinant osteogenic protein to repair bone or cartilage defects |
US7067637B1 (en) | 1992-02-12 | 2006-06-27 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Antibody or antibody fragments specific for a protein of the TGF-β family |
US6120760A (en) | 1992-02-12 | 2000-09-19 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung | Growth/differentiation factors of the TGF-β family |
US7025959B1 (en) | 1992-02-12 | 2006-04-11 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | MP121, a growth/differentiation factor of the TGF-β family |
US6171584B1 (en) | 1992-02-12 | 2001-01-09 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Method of treatment with growth/differentiation factors of the TGF-β family |
US5807713A (en) * | 1992-02-12 | 1998-09-15 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung | DNA encoding growth/differentiation factor |
DE19525416A1 (de) | 1995-07-12 | 1997-01-16 | Bioph Biotech Entw Pharm Gmbh | Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems |
WO1994015949A1 (en) | 1993-01-12 | 1994-07-21 | Johns Hopkins University School Of Medicine | Growth differentiation factor-5 |
CA2165778A1 (en) | 1993-07-09 | 1995-01-19 | Se-Jin Lee | Growth differentiation factor-7 |
AU697625B2 (en) * | 1993-07-09 | 1998-10-15 | Johns Hopkins University School Of Medicine, The | Growth differentiation factor-6 |
IL110589A0 (en) * | 1993-08-10 | 1994-11-11 | Bioph Biotech Entw Pharm Gmbh | Growth/differentiation factor of the TGF- beta family |
US6764994B1 (en) | 1993-08-10 | 2004-07-20 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Growth/differential factor of the TGF-B family |
US6027919A (en) * | 1993-12-07 | 2000-02-22 | Genetics Institute, Inc. | BMP-12 and BMP-13 proteins and DNA encoding them |
PT733109E (pt) | 1993-12-07 | 2006-07-31 | Genetics Inst Llc | Proteinas morfogeneticas dos 0ss0s pmo-12 e pmo-13 e as suas composicoes para inducao de tendao |
IL114397A0 (en) * | 1994-07-01 | 1995-10-31 | Bioph Biotech Entw Pharm Gmbh | Growth/differentiation factor of the TGF-beta-family |
CA2195246A1 (en) * | 1994-07-13 | 1996-02-01 | Se-Jin Lee | Growth differentiation factor-12 |
AU1120295A (en) | 1994-11-07 | 1996-05-31 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Cartilage-derived morphogenetic proteins |
US5846770A (en) * | 1994-11-22 | 1998-12-08 | Genetics Institute, Inc. | DNA molecules encoding human chordin |
CN100448890C (zh) * | 1995-04-19 | 2009-01-07 | Biopharm生物技术药物开发股份有限公司 | 来源于mp-52蛋白质的新型蛋白质及其制备方法和用途 |
NZ305472A (en) * | 1995-04-19 | 1999-09-29 | Hoechst Marion Roussel Ltd For | A protein derived from human mp52 useful in treating cartilage and bone diseases |
US5635372A (en) * | 1995-05-18 | 1997-06-03 | Genetics Institute, Inc. | BMP-15 compositions |
WO1996039169A1 (en) | 1995-06-05 | 1996-12-12 | Genetics Institute, Inc. | Methods and compositions for healing and repair of connective tissue attachment |
US5902785A (en) * | 1995-06-06 | 1999-05-11 | Genetics Institute, Inc. | Cartilage induction by bone morphogenetic proteins |
ZA966489B (en) * | 1995-08-03 | 1997-02-26 | Bioph Biotech Entw Pharm Gmbh | New protein human MP52 Arg. |
US5700774A (en) * | 1996-03-26 | 1997-12-23 | Genetics Institute, Inc. | Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same |
JPH1080273A (ja) * | 1996-05-13 | 1998-03-31 | Hoechst Yakuhin Kogyo Kk | Mp52に対するモノクローナル抗体 |
US5965403A (en) | 1996-09-18 | 1999-10-12 | Genetics Institute, Inc. | Nucleic acids encoding bone morphogenic protein-16 (BMP-16) |
EP0972520B9 (en) * | 1997-01-30 | 2006-03-22 | Biopharm Gesellschaft zur biotechnologischen Entwicklung von Pharmaka mbH | Freeze-dried composition of bone morphogenetic protein human mp52 |
US20010016646A1 (en) | 1998-03-20 | 2001-08-23 | David C. Rueger | Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
US7041641B2 (en) | 1997-03-20 | 2006-05-09 | Stryker Corporation | Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects |
JP2001526788A (ja) | 1997-05-30 | 2001-12-18 | クリエイティブ バイオモレキュールズ,インコーポレイテッド | 組織形態形成および活性を評価するための方法 |
US20020052026A1 (en) | 1997-10-08 | 2002-05-02 | Steven M. Vicik | Methods of refolding proteins |
US6027917A (en) * | 1997-12-10 | 2000-02-22 | Genetics Institute, Inc. | Bone morphogenetic protein (BMP)-17 and BMP-18 compositions |
US7147839B2 (en) | 1998-05-29 | 2006-12-12 | Curis, Inc. | Methods for evaluating tissue morphogenesis and activity |
US6727224B1 (en) | 1999-02-01 | 2004-04-27 | Genetics Institute, Llc. | Methods and compositions for healing and repair of articular cartilage |
DE19906096A1 (de) | 1999-02-13 | 2000-08-17 | Walter Sebald | Protein mit einem Heparin-bindenden Epitop |
TWI267378B (en) | 2001-06-08 | 2006-12-01 | Wyeth Corp | Calcium phosphate delivery vehicles for osteoinductive proteins |
DK1448246T4 (en) | 2001-11-19 | 2015-12-21 | Scil Technology Gmbh | Homogeneously coated device with osteoinductive and osteoconductive properties |
CN100522241C (zh) | 2002-09-10 | 2009-08-05 | Scil技术股份有限公司 | 在低氧气浓度下用骨诱导蛋白包被的金属植入物 |
US7344716B2 (en) | 2003-05-13 | 2008-03-18 | Depuy Spine, Inc. | Transdiscal administration of specific inhibitors of pro-inflammatory cytokines |
US7553827B2 (en) | 2003-08-13 | 2009-06-30 | Depuy Spine, Inc. | Transdiscal administration of cycline compounds |
US7429378B2 (en) | 2003-05-13 | 2008-09-30 | Depuy Spine, Inc. | Transdiscal administration of high affinity anti-MMP inhibitors |
US8273347B2 (en) | 2003-05-13 | 2012-09-25 | Depuy Spine, Inc. | Autologous treatment of degenerated disc with cells |
US8361467B2 (en) | 2003-07-30 | 2013-01-29 | Depuy Spine, Inc. | Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints |
EP2374471A1 (en) | 2003-09-12 | 2011-10-12 | Wyeth LLC | Injectable hardenable calcium phosphate pastes for delivery of osteogenic proteins |
US8895540B2 (en) | 2003-11-26 | 2014-11-25 | DePuy Synthes Products, LLC | Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
US8372419B2 (en) | 2004-03-10 | 2013-02-12 | Scil Technology Gmbh | Coated implants, their manufacturing and use thereof |
EP1740609A2 (en) | 2004-04-27 | 2007-01-10 | Research Development Foundation | Antagonism of tgf-beta superfamily receptor signaling |
AU2005247440B2 (en) | 2004-05-25 | 2011-09-29 | Stryker Corporation | Use of morphogenic proteins for treating cartilage defects |
US20060069008A1 (en) | 2004-09-28 | 2006-03-30 | Sanjay Mistry | Treatment of neurological deficits in the striatum or substanta nigra pars compacta |
US7473678B2 (en) | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
US8147860B2 (en) | 2005-12-06 | 2012-04-03 | Etex Corporation | Porous calcium phosphate bone material |
WO2007092622A2 (en) | 2006-02-09 | 2007-08-16 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating bone |
EP2540310A1 (en) | 2006-05-17 | 2013-01-02 | Stryker Corporation | Methods of treating cartilage defects using a soluble morphogenic protein complex |
AU2007269712B2 (en) | 2006-06-30 | 2013-02-07 | Biomimetic Therapeutics, Llc | PDGF-biomatrix compositions and methods for treating rotator cuff injuries |
US9161967B2 (en) | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
US8524265B2 (en) | 2006-08-17 | 2013-09-03 | Warsaw Orthopedic, Inc. | Medical implant sheets useful for tissue regeneration |
AU2007234612B2 (en) | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
EP2120859B1 (en) | 2006-12-21 | 2013-11-20 | Stryker Corporation | Sustained-release formulations comprising bmp-7 crystals |
ES2402672T3 (es) * | 2007-01-25 | 2013-05-07 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Uso del GDF-5 para el mejoramiento o el mantenimiento del aspecto dérmico |
US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
US8058237B2 (en) | 2007-08-07 | 2011-11-15 | Advanced Technologies & Regenerative Medicine, LLC | Stable composition of GDF-5 and method of storage |
US8986696B2 (en) | 2007-12-21 | 2015-03-24 | Depuy Mitek, Inc. | Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints |
ES2474194T3 (es) | 2008-02-13 | 2014-07-08 | Keith Hruska | PMO-7 para su uso en el tratamiento de la hiperplasia de la neo�ntima |
EP2276458A1 (en) | 2008-04-14 | 2011-01-26 | Advanced Technologies and Regenerative Medicine, LLC | Liquid buffered gdf-5 formulations |
US8870954B2 (en) | 2008-09-09 | 2014-10-28 | Biomimetic Therapeutics, Llc | Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries |
CN102369017A (zh) | 2009-02-12 | 2012-03-07 | 史赛克公司 | 用于微创系统性递送包含TGF-β超家族成员的蛋白质的组合物和方法 |
CA2752157A1 (en) | 2009-02-12 | 2010-08-19 | Stryker Corporation | Peripheral administration of proteins including tgf-.beta. superfamily members for systemic treatment of disorders and disease |
US20120148539A1 (en) | 2009-03-24 | 2012-06-14 | Moulay Hicham Alaoui-Ismaili | Methods and Compositions for Tissue Engineering |
US8609127B2 (en) | 2009-04-03 | 2013-12-17 | Warsaw Orthopedic, Inc. | Medical implant with bioactive material and method of making the medical implant |
US20110002897A1 (en) | 2009-06-11 | 2011-01-06 | Burnham Institute For Medical Research | Directed differentiation of stem cells |
WO2011031856A1 (en) | 2009-09-09 | 2011-03-17 | Stryker Corporation | Bmp -7 for use in treating pain induced by injuries and diseases of an articular joint |
JP2013518808A (ja) | 2009-09-17 | 2013-05-23 | ストライカー コーポレイション | 骨形成タンパク質のpHを制御するための緩衝液 |
EP2516456A1 (en) | 2009-12-22 | 2012-10-31 | Stryker Corporation | Bmp-7 variants with reduced immunogenicity |
BR112012020566B1 (pt) | 2010-02-22 | 2021-09-21 | Biomimetic Therapeutics, Llc | Composição de fator de crescimento derivado de plaqueta |
EP2598177B1 (en) | 2010-07-30 | 2015-06-17 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH | Drug delivery devices and growth factor formulations for accelerated wound healing |
EP2537538A1 (en) | 2011-06-22 | 2012-12-26 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH | Bioresorbable Wound Dressing |
US10034945B2 (en) | 2012-07-13 | 2018-07-31 | Trustees Of Tufts College | Silk powder compaction for production of constructs with high mechanical strength and stiffness |
CN108430458B (zh) | 2015-10-26 | 2022-05-10 | 哈佛学院院长等 | 还原和氧化的多糖及其使用方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL83003A (en) * | 1986-07-01 | 1995-07-31 | Genetics Inst | Factors that soak bone formation |
AU1539188A (en) * | 1987-05-04 | 1988-11-10 | Bristol-Myers Squibb Company | TGF-B2 and novel compositions having anti-neoplastic activity |
US5221620A (en) * | 1987-10-06 | 1993-06-22 | Oncogen | Cloning and expression of transforming growth factor β2 |
WO1990014360A1 (en) * | 1989-05-17 | 1990-11-29 | Oncogene Science, Inc. | Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
FI95398C (fi) * | 1989-06-24 | 1996-01-25 | Boehringer Ingelheim Int | Menetelmä ihmisen nuhaviruksen serotyypittämiseksi |
JP3045398B2 (ja) * | 1989-09-06 | 2000-05-29 | 武田薬品工業株式会社 | 蛋白質、dnaおよびその用途 |
DK0448704T3 (da) * | 1989-10-17 | 1999-04-06 | Stryker Corp | Osteogene anordninger |
JPH03147787A (ja) * | 1989-10-31 | 1991-06-24 | Takara Shuzo Co Ltd | 新しいdnaクローニング方法 |
-
1993
- 1993-02-12 JP JP51379393A patent/JP3193050B2/ja not_active Expired - Lifetime
- 1993-02-12 UA UA94085688A patent/UA48105C2/ru unknown
- 1993-02-12 ES ES93903966T patent/ES2141761T3/es not_active Expired - Lifetime
- 1993-02-12 HU HU9402143A patent/HU218845B/hu unknown
- 1993-02-12 DE DE69327645T patent/DE69327645T2/de not_active Expired - Lifetime
- 1993-02-12 CA CA002129820A patent/CA2129820C/en not_active Expired - Lifetime
- 1993-02-12 PT PT93903966T patent/PT625989E/pt unknown
- 1993-02-12 AT AT93903966T patent/ATE188996T1/de active
- 1993-02-12 WO PCT/EP1993/000350 patent/WO1993016099A2/en active IP Right Grant
- 1993-02-12 EP EP93903966A patent/EP0625989B1/en not_active Expired - Lifetime
- 1993-02-12 CZ CZ19941942A patent/CZ287715B6/cs not_active IP Right Cessation
- 1993-02-12 RU RU94046367/13A patent/RU2208638C2/ru active
- 1993-02-12 NZ NZ249113A patent/NZ249113A/en not_active IP Right Cessation
- 1993-02-12 KR KR1019940702756A patent/KR0172186B1/ko not_active IP Right Cessation
- 1993-02-12 DK DK93903966T patent/DK0625989T3/da active
-
1996
- 1996-10-30 JP JP28876696A patent/JP3493105B2/ja not_active Expired - Fee Related
-
1997
- 1997-04-08 CZ CZ19971069A patent/CZ287810B6/cs not_active IP Right Cessation
-
2000
- 2000-01-26 GR GR20000400177T patent/GR3032482T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
HU9402143D0 (en) | 1994-09-28 |
CA2129820A1 (en) | 1993-08-19 |
CA2129820C (en) | 2003-06-17 |
CZ287715B6 (en) | 2001-01-17 |
NZ249113A (en) | 1996-07-26 |
JPH07503847A (ja) | 1995-04-27 |
JP3193050B2 (ja) | 2001-07-30 |
WO1993016099A2 (en) | 1993-08-19 |
AU666170B2 (en) | 1996-02-01 |
EP0625989A1 (en) | 1994-11-30 |
KR950700331A (ko) | 1995-01-16 |
HU218845B (hu) | 2000-12-28 |
HUT67683A (en) | 1995-04-28 |
RU2208638C2 (ru) | 2003-07-20 |
UA48105C2 (ru) | 2002-08-15 |
DE69327645D1 (de) | 2000-02-24 |
GR3032482T3 (en) | 2000-05-31 |
EP0625989B1 (en) | 2000-01-19 |
CZ287810B6 (cs) | 2001-02-14 |
KR0172186B1 (ko) | 1999-02-01 |
AU3497193A (en) | 1993-09-03 |
ES2141761T3 (es) | 2000-04-01 |
CZ194294A3 (en) | 1995-10-18 |
WO1993016099A3 (en) | 1993-09-30 |
ATE188996T1 (de) | 2000-02-15 |
DK0625989T3 (da) | 2000-06-26 |
JP3493105B2 (ja) | 2004-02-03 |
JPH09182593A (ja) | 1997-07-15 |
DE69327645T2 (de) | 2000-09-07 |
PT625989E (pt) | 2000-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94046367A (ru) | Днк, хозяйская клетка, способ получения белка, белок, фармацевтический препарат, антитело, применение антитела | |
ATE309271T1 (de) | Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen | |
RU94045919A (ru) | Антитела, клетки, полипептид, днк векторы, способ получения полипептида, способ получения антитела, фармацевтическая композиция | |
RU95108217A (ru) | Дефектный рекомбинантный аденовирус, линия клеток, фармацевтическая композиция | |
RU95115239A (ru) | Аналог эритропоэтина | |
AU2002305450A1 (en) | Proteomimetic compounds and methods | |
ATE251464T1 (de) | Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen | |
DE69929612D1 (de) | Purifikation von viruspräparaten | |
NO914206L (no) | Terapeutisk middel | |
DE69132814D1 (de) | Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5 | |
AU6745287A (en) | Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins | |
KR910002520B1 (ko) | 세포 성장 억제 인자 | |
ATE208815T1 (de) | Genetisches igfbp-5 rodierendes material | |
FR2726472B1 (fr) | Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin | |
FI972170A (fi) | Peptidejä, jotka kykenevät sitoutumaan GAP-proteiinin SH3-domeeniin, näitä peptidejä koodittavia nukleotidisekvenssejä, niiden valmistus ja käyttö | |
RU94045930A (ru) | Белки, днк, вектор, клетка, способы получения и очистки белка, фармацевтическая композиция | |
WO2001040313A3 (en) | Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof | |
ATE263239T1 (de) | Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) | |
EP0369816A3 (en) | Monoclonal antibodies specific for human polymorphic epithelial mucin | |
CA2002833A1 (en) | Interferon-gamma binding proteins | |
WO2005095445A1 (ja) | 新規塩基性抗菌ペプチド及びその利用 | |
UA5743C2 (ru) | Препарат тканевых биологически активных веществ, обладающий регенаторным действием, и способ его получения | |
Ganguly et al. | Tyrosine phosphorylation of a 94-kDa protein of human fibroblasts stimulated by streptococcal lipoteichoic acid. | |
Prixova et al. | Bactericidal substances in cytoplasm of leucocytes. An attempt to separate lysozyme by gel filtration | |
RU95101019A (ru) | Способ получения фактора некроза опухоли, фактор некроза опухоли, днк, клетка, композиция |